We just received data on a new analyst forecast for $TDY. Morgan Stanley gave a rating of 'Equal-Weight' for $TDY.
$TDY Analyst Ratings
Wall Street analysts have issued reports on $TDY in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 06/24/2025
- TD Securities issued a "Buy" rating on 04/24/2025
- Needham issued a "Buy" rating on 04/24/2025
- B of A Securities issued a "Buy" rating on 03/17/2025
To track analyst ratings and price targets for $TDY, check out Quiver Quantitative's $TDY forecast page.
$TDY Price Targets
Multiple analysts have issued price targets for $TDY recently. We have seen 5 analysts offer price targets for $TDY in the last 6 months, with a median target of $580.0.
Here are some recent targets:
- Kristine Liwag from Morgan Stanley set a target price of $580.0 on 07/17/2025
- Jonathan Siegmann from Stifel set a target price of $626.0 on 06/24/2025
- Joe Giordano from TD Securities set a target price of $550.0 on 04/24/2025
- James Ricchiuti from Needham set a target price of $550.0 on 04/24/2025
- Ronald Epstein from B of A Securities set a target price of $600.0 on 03/17/2025
$TDY Congressional Stock Trading
Members of Congress have traded $TDY stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TDY stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
- REPRESENTATIVE APRIL MCCLAIN DELANEY sold up to $50,000 on 02/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$TDY Insider Trading Activity
$TDY insiders have traded $TDY stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $TDY stock by insiders over the last 6 months:
- ROBERT MEHRABIAN (Executive Chairman) has made 0 purchases and 7 sales selling 37,305 shares for an estimated $19,142,729.
- MELANIE SUSAN CIBIK (EVP, GenCounsel, CCO & Sec.) has made 0 purchases and 4 sales selling 10,808 shares for an estimated $5,527,348.
- GEORGE C III BOBB (President and COO) has made 0 purchases and 5 sales selling 6,308 shares for an estimated $3,203,013.
- CYNTHIA Y BELAK (Vice President and Controller) has made 0 purchases and 11 sales selling 5,745 shares for an estimated $2,920,408.
- STEPHEN FINIS BLACKWOOD (Senior VP and CFO) has made 0 purchases and 2 sales selling 5,046 shares for an estimated $2,591,706.
- JASON VANWEES (Vice Chairman) sold 3,700 shares for an estimated $1,924,204
- MICHAEL T SMITH sold 2,100 shares for an estimated $1,072,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TDY Hedge Fund Activity
We have seen 334 institutional investors add shares of $TDY stock to their portfolio, and 313 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 495,653 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $253,927,988
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 394,718 shares (-30.1%) from their portfolio in Q1 2025, for an estimated $196,455,095
- FIL LTD added 251,057 shares (+96.5%) to their portfolio in Q1 2025, for an estimated $124,953,579
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 232,401 shares (+56.9%) to their portfolio in Q1 2025, for an estimated $115,668,301
- CONGRESS ASSET MANAGEMENT CO removed 208,838 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $106,989,795
- BLACKROCK, INC. added 199,262 shares (+5.2%) to their portfolio in Q1 2025, for an estimated $99,174,690
- MILLENNIUM MANAGEMENT LLC removed 178,152 shares (-83.2%) from their portfolio in Q1 2025, for an estimated $88,668,031
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
